No Data
Milestone Pharmaceuticals Bolsters Board With New Directors
Milestone Pharmaceuticals Appoints Two New Independent Directors, Stuart Duty and Andrew Saik >MIST
Milestone Pharmaceuticals Price Target Maintained With a $25.00/Share by HC Wainwright & Co.
THE MILESTONE GROUP ANNOUNCES ACQUISITION OF AXIS DELRAY BEACH APARTMENTS IN DELRAY BEACH, FLORIDA
TD Cowen Maintains Milestone Pharmaceuticals(MIST.US) With Buy Rating, Maintains Target Price $9
TD Cowen analyst Ritu Baral maintains $Milestone Pharmaceuticals(MIST.US)$ with a buy rating, and maintains the target price at $9.According to TipRanks data, the analyst has a success rate of 44.8% a
Piper Sandler Maintains Milestone Pharmaceuticals(MIST.US) With Buy Rating, Maintains Target Price $5
Piper Sandler analyst Edward Tenthoff maintains $Milestone Pharmaceuticals(MIST.US)$ with a buy rating, and maintains the target price at $5.According to TipRanks data, the analyst has a success rate